United Orthopedic Group, Inc.

United Orthopedic Group, Inc. focuses on developing and distributing orthopedic products to improve patient mobility and comfort, particularly for those recovering from musculoskeletal injuries. United Orthopedic Group, Inc. specializes in orthopedic products aimed at enhancing patient mobility.

The company is headquartered in Carlsbad, US. In October 2014, United Orthopedic Group was acquired by Breg, Inc. , a portfolio company of Water Street Healthcare Partners, although financial terms were not disclosed. The company has participated in 3 investment deals, with the most recent round being a VENTURE DEBT funding of USD 20.

00 mn from Oxford Finance Corporation. United Ortho Group specializes in the development and distribution of orthopedic products designed to enhance patient mobility and comfort. Their core offerings include a range of braces and supports tailored to various musculoskeletal conditions, focusing primarily on knee, ankle, and back injuries. These products are engineered to provide stabilization, reduce pain, and facilitate recovery, addressing the needs of both healthcare professionals and patients.

The company primarily serves physical therapists, orthopedic clinics, and hospitals, ensuring that their products are readily available for patients requiring orthopedic support. United Ortho Group’s products are sold primarily in North America and select markets in Europe, catering to a diverse clientele that includes athletic populations, patients recovering from surgery, and individuals with chronic conditions. United Ortho Group generates revenue through direct sales to healthcare providers and institutions, operating within a B2B sales model. Transactions are structured around bulk orders from clinics and hospitals, as well as individual sales through partnerships with medical supply retailers.

The company's flagship products are typically included in comprehensive supply agreements with major healthcare providers, facilitating a steady stream of revenue. Pricing plans for their orthopedic products vary based on the specific type and complexity of the items, allowing for tailored solutions that meet the needs of their clients. Overall, the company's revenue structure is supported by a combination of direct sales and strategic partnerships, reinforcing its position within the orthopedic market. United Orthopedic Group plans to leverage the recent VENTURE DEBT funding to enhance its product offerings and expand into new markets.

They are currently designing new orthopedic products aimed at improving recovery times and patient outcomes, with plans for release in the next 12 to 18 months. The company is also targeting expansion into additional European markets, aiming for a presence in these regions by the end of 2025.